FDA Guidelines on First in Class First in Man Compounds Targeting Tumor Bioenergetics from Lab Bench to Clinical Trials - Webinar By GlobalCompliancePanel 2012

  • 23 Aug 2012
  • Webinar

Description

FDA Guidelines on First in Class First in Man Compounds Targeting Tumor Bioenergetics from Lab Bench to Clinical Trials is a webinar that covers topics such as:

  • Review of relevant FDA regulation, guidelines and points to consider for manufacturing and drug product composition
  • Introduction into nanotechnology drug delivery and needs for improvement
  • Clinical development planning and path to approvals
  • Clinical research to support clinical development and protocol preparation for human study working with the FDA

FDA Guidelines on First in Class First in Man Compounds Targeting Tumor Bioenergetics from Lab Bench to Clinical Trials brings together Regulatory Affairs Managers, Directors and VPs, Formulation Scientists and Researchers, Manufacturing Managers, Directors and VPs, Quality Managers, Directors and VPs, Strategic Planning Managers, Directors and VPs.

Past Events

Important

Please, check "FDA Guidelines on in Class in Man Compounds Targeting Tumor Bioenergetics from Lab Bench to Clinical Trials - Webinar By GlobalCompliancePanel" official website for possible changes, before making any traveling arrangements

Event Categories

Health & Medicine: Medical device, Pharma
Technology: Biotechnology

Other Events with Similar Categories

Other Events with Similar Location or Organizer

Featured Conferences & Exhibitions